课题基金 / 基金详情

Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes

Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
批准号:
8447090
负责人:
BRAD T COOKSON
金额:
$23.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
关键词:
Animal ModelApoptosisAttenuatedB-LymphocytesBacteriaBacterial GenesBacterial InfectionsBioinformaticsBromodeoxyuridineBubonic PlagueBurkholderiaCaspase-1CategoriesCell DeathCellsCenters of Research ExcellenceCharacteristicsClinicalConditioned Culture MediaCultured CellsDataDetectionDiagnosisDiagnosticDiseaseEarly InterventionElementsEmerging Communicable DiseasesEnvironmentEventFailureFrancisellaGenesGrowthHourHumanHyperplasiaImmuneImmune responseImmunityImmunophenotypingIndividualInfectionInflammationInflammatoryInflammatory ResponseInvestigationKnockout MiceLabelLaboratoriesLibrariesLifeLungLymphadenitisLymphocyteLymphoidMacrophage ActivationMediatingModificationMusMutagenesisMutationOrganismOutcomePasteurella pseudotuberculosisPathogenesisPatientsPattern recognition receptorPlaguePlasmidsPlayPredispositionProcessProductionProliferatingProteinsProteomicsPublic HealthReceptor SignalingRegulationReverse Transcriptase Polymerase Chain ReactionRoleSepsisSignal PathwaySignal TransductionStagingStaining methodStainsStimulusSubunit VaccinesSurfaceSystemSystemic infectionT-LymphocyteTLR2 geneTLR4 geneTemperatureTestingTherapeuticTissuesTransgenic MiceType III Secretion System PathwayVirulenceWorkYersiniaYersinia infectionsYersinia pestisantimicrobialbiodefensecytokinedesigndisease diagnosisexperienceextracellulargenetic regulatory proteinimprovedin vivoinfected B cellinsightinterdisciplinary approachkillingslymph nodeslymphocyte proliferationlymphoid hyperplasiamacrophagemutantpathogenresearch studyresponsesuccesstreatment strategy

项目摘要

项目成果

BRAD T COOKSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Plague has killed millions of humans, providing objective concern that Yersinia pestis could be used to threaten public health. Y. pestis evolved from Y. pseudotuberculosis. Both are lymphotropic and cause strikingly bi-phasic illnesses: initial bacterial replication without inflammation gives way to profound inflammation, tissue destruction, and clinical disease. Replication without effective host responses in early infection is also characteristic of Burkholderia and Francisella. Only early intervention can save infected patients and a better understanding of the initial stages of infection, and how innate responses are delayed, will improve approaches to diagnosis and treatment. Bacterial attributes and host responses during early lymph node infection remain largely unstudied. Yersinia surface and secreted proteins, which are likely to be critical for early infection and are also candidates for subunit vaccines or diagnostic markers, will be identified using proteomics, bioinformatics and expression array studies. Investigation will focus on bacterial strains with defined mutations in genes known to regulate surface changes and comparing bacteria responding to environmental stimuli that effectively mimic the host environment. Bacterial mutants lacking these proteins will be assessed for growth in host lymph nodes using an experimental system that is not complicated by the myriad effects of the plasmid-encoded secretion system. Host contributions to limiting bacterial growth in the lymph node, and the lymphoid proliferation triggered by Yersinia infections, will be investigated to understand which lymphocytes are proliferating and whether or not they are activated and contributing cytokines to help limit infection. Precise modulation of inflammation is required for bacterial replication to occur in vivo, and therefore the contributions of both cellular activation and the production of cytokines will be evaluated in the context of host responses to: i) bacterial strains that colonize lymph nodes, and ii) defective hyper-inflammatory strains that fail to colonize. This project will provide a greater understanding of innate immune responses to infection and provide relevant data for designing optimal diagnostic and treatment strategies that favor quality outcomes for the infected host.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Caliper Life Sciences IVIS Lumina II imaging system
  • 批准号:
    8246848
  • 项目类别:
  • 资助金额:
    $16.11万
  • 财政年份:
    2012
  • 负责人:
    BRAD T COOKSON
  • 依托单位:
Career Development and Training Program
  • 批准号:
    8236995
  • 项目类别:
  • 资助金额:
    $33.83万
  • 财政年份:
    2011
  • 负责人:
    BRAD T COOKSON
  • 依托单位:
Development Research Plan
  • 批准号:
    8236993
  • 项目类别:
  • 资助金额:
    $43.86万
  • 财政年份:
    2011
  • 负责人:
    BRAD T COOKSON
  • 依托单位:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
  • 批准号:
    8236985
  • 项目类别:
  • 资助金额:
    $30.77万
  • 财政年份:
    2011
  • 负责人:
    BRAD T COOKSON
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: